better data.
better brains.

Kernel is revolutionizing precision neuroscience. We are using our proprietary, first-in-class neurotechnology to build the world's most comprehensive portfolio of brain-based biomarkers. Our mission is to accelerate treatment discovery, improve patient outcomes, and transform neuromedicine.

Partner With Us

What We Do

Unlocking Precision Neuroscience with Kernel Flow

Kernel Flow collects high-resolution data at the scale required for precision neuroscience. By applying state-of-the-art AI and ML tools to this data, we are developing new biomarkers and drawing unprecedented, actionable insights.

Exceptional Ease-of-Use

Kernel Flow is portable and takes minutes to set up, bringing research-grade neuroimaging to a wide range of real-world settings.

Validated and Trusted

Peer-reviewed and backed by over 5000 unique datasets, Kernel Flow builds on decades of scientific developments and has been proven in the field.

Superior Data

Kernel Flow is the first and only multimodal neuroimaging headset that combines high resolution optical hemodynamic imaging, providing fMRI-like cortical measures, with EEG measures, providing advanced, multi-modal data for comprehensive insights.

Immediate Insights

Kernel's cutting-edge data processing pipelines provide seamless access to world-class data analyses with a single click. Our analysis tools are cloud-based and scalable, enabling the processing of individual datasets as well as large-scale population-level analyses.

Capabilities

Accelerating Treatment Development

Translational Research

Measurement and analysis to identify target engagement

Clinical Trial Optimization

Population stratification and quantitative endpoints provide enhanced precision in detecting drug effects, determining treatment efficacy and discerning more accurately when a drug is ineffective.

Neuromedicine: Improving Care

Predicting Treatment Response

Selecting from menu of treatments based on neuro biomarkers

Early Identification

Until now, the widespread accessibility of advanced neuroimaging technologies has been limited, hindering regular brain measurements and early detection of brain changes for follow-up purposes.